SEC Form 4 · accession 0001104659-18-041871
STEMLINE THERAPEUTICS INC · STML
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Sard
Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 22, 2018 · 9:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001264587
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 21, 2018 | A | 20,468 | $0.00 | A | 36,468 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted shares will vest according to the following schedule: 6,823 shares on 6/21/2019, 6,823 shares on 6/21/2020 and 6,822 shares on 6/21/2021.
- F2Of the 36,468 shares, 20,468 shares are restricted stock.